Current Nutraceuticals

Author(s): Nahed Ahmed Hussien* and Ghazwaa Awad Alsulami

DOI: 10.2174/2665978601999200928212236

DownloadDownload PDF Flyer Cite As
Anticancer Potential of Lepidium Sativum Seeds Aqueous Extract on the Azoxymethane/ Dextran Sulfate Sodium-Induced Colon Cancer In vivo

Page: [78 - 88] Pages: 11

  • * (Excluding Mailing and Handling)

Abstract

Background: Colon cancer is responsible for increasing the death rate worldwide. Commonly used anticancer drugs have various side effects and their clinical usage must be restricted due to their toxicity.

Objective: The present research aimed to evaluate the anticancer potential of Lepidium sativum L. (LS) seeds aqueous extract against azoxymethane/dextran sodium sulfate (AOM/DSS) inducedcolon cancer in male albino mice.

Methods: Low (200 mg/kg) and high (400 mg/kg) doses of LS seeds extract were used to treat induced colon cancer in different stages.

Results: The present results report that LS treatment for mice with colon cancer especially in high dose, decreases colon polyps/tumor incidence and size, tissues disorder, expression of P53 and increases apoptosis in colon tissue. Moreover, LS decreases micronucleus induction in polychromatic (PCE), increases PCE/normochromatic erythrocytes ratio and decreases the percentage of sperm abnormalities.

Conclusion: The present study reports anticancer potential of LS for induced colorectal cancer mice by ameliorating the inflammatory steps of colon.

Keywords: Lepidium sativum, colitis, colorectal cancer, azoxymethane, dextran sodium sulfate, male albino mice.